• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管蛋白质组学:进展与潜力

Cardiovascular proteomics: evolution and potential.

作者信息

Arrell D K, Neverova I, Van Eyk J E

机构信息

Departments of Physiology, Queen's University, Kingston, Ontario, Canada.

出版信息

Circ Res. 2001 Apr 27;88(8):763-73. doi: 10.1161/hh0801.090193.

DOI:10.1161/hh0801.090193
PMID:11325867
Abstract

The development of proteomics is a timely one for cardiovascular research. Analyses at the organ, subcellular, and molecular levels have revealed dynamic, complex, and subtle intracellular processes associated with heart and vascular disease. The power and flexibility of proteomic analyses, which facilitate protein separation, identification, and characterization, should hasten our understanding of these processes at the protein level. Properly applied, proteomics provides researchers with cellular protein "inventories" at specific moments in time, making it ideal for documenting protein modification due to a particular disease, condition, or treatment. This is accomplished through the establishment of species- and tissue-specific protein databases, providing a foundation for subsequent proteomic studies. Evolution of proteomic techniques has permitted more thorough investigation into molecular mechanisms underlying cardiovascular disease, facilitating identification not only of modified proteins but also of the nature of their modification. Continued development should lead to functional proteomic studies, in which identification of protein modification, in conjunction with functional data from established biochemical and physiological methods, has the ability to further our understanding of the interplay between proteome change and cardiovascular disease.

摘要

蛋白质组学的发展对心血管研究来说恰逢其时。在器官、亚细胞和分子水平上的分析揭示了与心脏和血管疾病相关的动态、复杂且微妙的细胞内过程。蛋白质组学分析的强大功能和灵活性有助于蛋白质的分离、鉴定和表征,应能加速我们在蛋白质水平上对这些过程的理解。如果应用得当,蛋白质组学能在特定时刻为研究人员提供细胞蛋白质“清单”,这使其成为记录因特定疾病、状况或治疗导致的蛋白质修饰的理想方法。这是通过建立物种和组织特异性蛋白质数据库来实现的,为后续的蛋白质组学研究奠定基础。蛋白质组学技术的发展使得对心血管疾病潜在分子机制的研究更加深入,不仅有助于鉴定修饰的蛋白质,还能确定其修饰的性质。持续的发展应能导向功能蛋白质组学研究,在这类研究中,蛋白质修饰的鉴定与来自既定生化和生理方法的功能数据相结合,将有助于我们进一步理解蛋白质组变化与心血管疾病之间的相互作用。

相似文献

1
Cardiovascular proteomics: evolution and potential.心血管蛋白质组学:进展与潜力
Circ Res. 2001 Apr 27;88(8):763-73. doi: 10.1161/hh0801.090193.
2
[Applications of proteomic approach in studying cardiovascular diseases].蛋白质组学方法在心血管疾病研究中的应用
Sheng Li Ke Xue Jin Zhan. 2004 Jul;35(3):237-9.
3
Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome: Where There Is a Will, There Is a Way.精准解析心血管翻译后修饰蛋白质组:有志者事竟成。
Circ Res. 2018 Apr 27;122(9):1221-1237. doi: 10.1161/CIRCRESAHA.118.310966.
4
Proteome analysis by mass spectrometry.基于质谱分析法的蛋白质组分析。
Annu Rev Biophys Biomol Struct. 2003;32:399-424. doi: 10.1146/annurev.biophys.32.110601.141854. Epub 2003 Jan 28.
5
Cardiovascular proteomic analysis.心血管蛋白质组学分析
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug;855(1):28-34. doi: 10.1016/j.jchromb.2007.02.043. Epub 2007 Mar 4.
6
Proteomic methods for biomarker discovery in a rat model of alcohol steatosis.在酒精性脂肪变性大鼠模型中发现生物标志物的蛋白质组学方法。
Methods Mol Biol. 2012;909:259-77. doi: 10.1007/978-1-61779-959-4_17.
7
Proteomic analysis of Bacillus anthracis Sterne vegetative cells.炭疽芽孢杆菌斯特恩株营养细胞的蛋白质组学分析
Biochim Biophys Acta. 2005 May 15;1748(2):191-200. doi: 10.1016/j.bbapap.2005.01.007.
8
Zooming in: fractionation strategies in proteomics.深入探讨:蛋白质组学中的分级分离策略
Proteomics. 2004 Dec;4(12):3704-16. doi: 10.1002/pmic.200401048.
9
Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.利用胶外等电聚焦和无标记定量液相色谱-质谱技术挖掘酸性血清蛋白质组。
J Chromatogr A. 2018 Sep 7;1566:32-43. doi: 10.1016/j.chroma.2018.06.044. Epub 2018 Jun 19.
10
[Cardiovascular proteomics: challenges and opportunities for cardiologists of the future].[心血管蛋白质组学:未来心脏病学家面临的挑战与机遇]
G Ital Cardiol (Rome). 2013 Jul-Aug;14(7-8):495-503. doi: 10.1714/1308.14458.

引用本文的文献

1
Cracking the Kinase Code: Urinary Biomarkers as Early Alarms for AAA Rupture-A Pilot Study.破解激酶密码:尿生物标志物作为腹主动脉瘤破裂的早期警报——一项初步研究
J Clin Med. 2025 May 29;14(11):3845. doi: 10.3390/jcm14113845.
2
Discovery of plasma proteome markers associated with clinical outcome and immunological stress after cardiac surgery.心脏手术后与临床结局和免疫应激相关的血浆蛋白质组标志物的发现。
Front Cardiovasc Med. 2023 Dec 22;10:1287724. doi: 10.3389/fcvm.2023.1287724. eCollection 2023.
3
Proteomics of the heart.心脏蛋白质组学。
Physiol Rev. 2024 Jul 1;104(3):931-982. doi: 10.1152/physrev.00026.2023. Epub 2024 Feb 1.
4
Phosphoproteomic and proteomic profiling in post-infarction chronic heart failure.心肌梗死后慢性心力衰竭的磷酸化蛋白质组学和蛋白质组学分析
Front Pharmacol. 2023 Jun 19;14:1181622. doi: 10.3389/fphar.2023.1181622. eCollection 2023.
5
High-Field Asymmetric Waveform Ion Mobility Spectrometry: Practical Alternative for Cardiac Proteome Sample Processing.高场非对称波形离子淌度谱:心肌蛋白质组样品处理的实用选择。
J Proteome Res. 2023 Jun 2;22(6):2124-2130. doi: 10.1021/acs.jproteome.3c00027. Epub 2023 Apr 11.
6
Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF).射血分数保留的心力衰竭(HFpEF)中的蛋白质组学和磷酸化蛋白质组学分析
Front Cardiovasc Med. 2022 Aug 25;9:966968. doi: 10.3389/fcvm.2022.966968. eCollection 2022.
7
The Ramp Atlas: facilitating tissue and cell-specific ramp sequence analyses through an intuitive web interface.Ramp图谱:通过直观的网络界面促进组织和细胞特异性ramp序列分析。
NAR Genom Bioinform. 2022 May 30;4(2):lqac039. doi: 10.1093/nargab/lqac039. eCollection 2022 Jun.
8
Impairment of Multiple Mitochondrial Energy Metabolism Pathways in the Heart of Chagas Disease Cardiomyopathy Patients.克氏锥虫病心肌病患者心脏中多个线粒体能量代谢途径的损伤。
Front Immunol. 2021 Nov 12;12:755782. doi: 10.3389/fimmu.2021.755782. eCollection 2021.
9
Proteomics analysis identified peroxiredoxin 2 involved in early-phase left ventricular impairment in hamsters with cardiomyopathy.蛋白质组学分析确定了过氧化物酶体增殖物激活受体2与患心肌病仓鼠的早期左心室损伤有关。
PLoS One. 2018 Feb 13;13(2):e0192624. doi: 10.1371/journal.pone.0192624. eCollection 2018.
10
Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics.基于质谱的蛋白质组学对缺血性中风候选生物标志物的发现与纵向评估
Biomark Insights. 2017 Dec 20;12:1177271917749216. doi: 10.1177/1177271917749216. eCollection 2017.